Kadowaki Sachiko, Fan Chun-Po Steve, Zahiri Yasmin, Yap Kok Hooi, Tocharoenchok Teerapong, Dipchand Anne I, Honjo Osami, Barron David J
Division of Cardiovascular Surgery, The Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Department of Surgery, University of Toronto, Toronto, ON, Canada.
Eur J Cardiothorac Surg. 2025 Feb 4;67(2). doi: 10.1093/ejcts/ezaf025.
This study aimed to assess the outcomes of heterotaxy patients who underwent the Fontan operation, focusing on morphological features and surgical techniques.
Eighty-two consecutive heterotaxy patients who underwent the Fontan operation from 1985 to 2021 were compared to 150 patients with tricuspid atresia (TA) and 144 patients with hypoplastic left heart syndrome (HLHS). The Kaplan-Meier method and Cox proportional hazard model were used to analyse transplant-free survival and predictor of outcomes.
The 20-year transplant-free survival rates were comparable between right atrial isomerism (RAI, n = 45) and left atrial isomerism (LAI, n = 37) [RAI versus LAI, 76% (95% confidence interval, 57-87%) vs 68% (47-82%), P = 0.22], although more pulmonary vein interventions at Fontan were needed in RAI. Surgical techniques included extracardiac conduit in 66%, intra-atrial conduit in 9% and lateral tunnel in 18% of the cases. Cardiac position and apicocaval juxtaposition did not influence outcomes, but the inferior vena cava (IVC)-contralateral pulmonary artery (PA) Fontan was associated with 100% survival, while the IVC-ipsilateral PA Fontan at the cardiac apex showed a 67% (34-87%) survival rate at 20 years. In-hospital mortality was higher in heterotaxy [9.8% (5-19%)] compared to TA [1.3% (0.3-5.3%), P<0.01) and HLHS [2.8% (1.1-7.3%), P = 0.02], with no early death after 2000 in any group. The 20-year transplant-free survival in heterotaxy [72% (59-82%)] was similar to that in HLHS [80% (69-87%), P = 0.11].
Various routing techniques can be successfully applied to overcome anatomical challenges in heterotaxy. Despite higher in-hospital mortality, overall survival was similar to HLHS. RAI had comparable survival to LAI with more pulmonary vein interventions at Fontan.
本研究旨在评估接受Fontan手术的异构心患者的手术结果,重点关注形态学特征和手术技术。
将1985年至2021年连续接受Fontan手术的82例异构心患者与150例三尖瓣闭锁(TA)患者和144例左心发育不全综合征(HLHS)患者进行比较。采用Kaplan-Meier法和Cox比例风险模型分析无移植生存率及预后预测因素。
右房异构(RAI,n = 45)和左房异构(LAI,n = 37)的20年无移植生存率相当[RAI与LAI相比,分别为76%(95%置信区间,57 - 87%)和68%(47 - 82%),P = 0.22],尽管RAI患者在Fontan手术中需要更多的肺静脉干预。手术技术包括66%的患者采用心外管道、9%的患者采用心房内管道、18%的患者采用侧隧道。心脏位置和心尖与腔静脉并列对预后无影响,但下腔静脉(IVC)-对侧肺动脉(PA)Fontan手术的生存率为100%,而心脏尖部的IVC-同侧PA Fontan手术在20年时的生存率为67%(34 - 87%)。异构心患者的住院死亡率[9.8%(5 - 19%)]高于TA患者[1.3%(0.3 - 5.3%),P<0.01]和HLHS患者[2.8%(1.1 - 7.3%),P = 0.02],2000年后各组均无早期死亡。异构心患者的20年无移植生存率[72%(59 - 82%)]与HLHS患者[80%(69 - 87%),P = 0.11]相似。
各种路径技术可成功应用于克服异构心中的解剖学挑战。尽管住院死亡率较高,但总体生存率与HLHS相似。RAI的生存率与LAI相当,但在Fontan手术中需要更多的肺静脉干预。